Integrated immunogenicity analysis of a tetravalent dengue vaccine up to 4 y after vaccination

Two large pivotal phase III studies demonstrated the efficacy of the tetravalent dengue vaccine (CYD-TDV; Dengvaxia®, Sanofi Pasteur) against all dengue serotypes. Here we present an unprecedented integrated summary of the immunogenicity of CYD-TDV to identify the parameters driving the neutralizing...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Hum Vaccin Immunother
Main Authors: Vigne, Claire, Dupuy, Martin, Richetin, Aline, Guy, Bruno, Jackson, Nicholas, Bonaparte, Matthew, Hu, Branda, Saville, Melanie, Chansinghakul, Danaya, Noriega, Fernando, Plennevaux, Eric
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2017
Assuntos:
Research Papers
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5612045/
https://ncbi.nlm.nih.gov/pubmed/28598256
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2017.1333211
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados